Completion rates of intraperitoneal chemotherapy for stage III epithelial ovarian cancer in a community integrated health care system

被引：0
|
作者：
Lazo, I. [1 ]
White, K. [1 ]
Tucker, L. [2 ]
Zaritsky, E. [1 ]
Han, L. [1 ]
Ciaravino, G. [1 ]
机构：
[1] Kaiser Permanente, Oakland Med Ctr, Dept Obstet & Gynecol, Oakland, CA USA
[2] Kaiser Permanente, Div Res, Oakland, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 139卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2015.07.073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [1] Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer - Our Experience
    Jaka, R. C.
    Zaveri, S.
    Somashekhar, S. P.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S531 - S531
  • [2] Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: A review of complications and completion rates
    Landrum, Lisa M.
    Gold, Michael A.
    Moore, Kathleen N.
    Myers, Tashanna K. N.
    McMeekin, D. S.
    Walker, Joan L.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (02) : 342 - 347
  • [3] Intraperitoneal chemotherapy for stage III ovarian cancer - In reply
    Alberts, DS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) : 957 - 958
  • [4] Intraperitoneal chemotherapy: standard of care for patients with minimal residual stage III ovarian cancer?
    Tummala, Mohan K.
    Alagarsamy, Suganthi
    McGuire, William P.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (07) : 1135 - 1147
  • [5] Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
    Lei, Ziying
    Wang, Yue
    Wang, Jiahong
    Wang, Ke
    Tian, Jun
    Zhao, Ying
    Chen, Lipai
    Wang, Jin
    Luo, Jiali
    Jia, Manman
    Tang, Hongsheng
    He, Qingjun
    Liao, Quanxing
    Yang, Xiansheng
    Guan, Tianpei
    Wang, Li
    Cui, Shuzhong
    JAMA NETWORK OPEN, 2020, 3 (08) : E2013940
  • [6] Intraperitoneal chemotherapy for epithelial ovarian cancer
    AlHayki, Maryam
    Hopkins, Laura
    Le, Tien
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2006, 61 (08) : 529 - 534
  • [7] Optimally Debulked Stage III Ovarian Cancer Intraperitoneal or Intravenous Chemotherapy?
    Friedlander, Michael
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 : S20 - S23
  • [8] Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer Is Feasible With High Completion Rates, Low Complications, and Acceptable Patient Outcomes
    Skaznik-Wikiel, Malgorzata E.
    Lesnock, Jamie L.
    Mcbee, William C.
    Beriwal, Sushil
    Zorn, Kristin K.
    Richard, Scott D.
    Krivak, Thomas C.
    Edwards, Robert P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (02) : 232 - 237
  • [9] Patient factors associated with completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer
    Moulton, L. J.
    DeBernardo, R.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 204 - 205
  • [10] Evaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer
    Chambers, Laura Moulton
    Son, Ji
    Radeva, Milena
    DeBernardo, Robert
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (06)
12345